513 related articles for article (PubMed ID: 27903516)
1. Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
Spradley FT
Am J Physiol Regul Integr Comp Physiol; 2017 Jan; 312(1):R5-R12. PubMed ID: 27903516
[TBL] [Abstract][Full Text] [Related]
2. Immune Mechanisms Linking Obesity and Preeclampsia.
Spradley FT; Palei AC; Granger JP
Biomolecules; 2015 Nov; 5(4):3142-76. PubMed ID: 26569331
[TBL] [Abstract][Full Text] [Related]
3. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms.
Spradley FT; Palei AC; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(11):R1326-43. PubMed ID: 26447211
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
5. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
6. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
8. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
[TBL] [Abstract][Full Text] [Related]
9. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
10. [PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].
Manolov V; Marinov B; Vasilev V
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():61-9. PubMed ID: 24294749
[TBL] [Abstract][Full Text] [Related]
11. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.
Weel IC; Baergen RN; Romão-Veiga M; Borges VT; Ribeiro VR; Witkin SS; Bannwart-Castro C; Peraçoli JC; De Oliveira L; Peraçoli MT
PLoS One; 2016; 11(6):e0157584. PubMed ID: 27315098
[TBL] [Abstract][Full Text] [Related]
12. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
13. [Potential for diagnosis in preeclampsia].
Marinov B; Manolov V; Vasilev V; Andonova I
Akush Ginekol (Sofiia); 2013; 52 Suppl 2():49-55. PubMed ID: 24294763
[TBL] [Abstract][Full Text] [Related]
14. Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women.
Nerenberg KA; Johnson JA; Leung B; Savu A; Ryan EA; Chik CL; Kaul P
J Obstet Gynaecol Can; 2013 Nov; 35(11):986-994. PubMed ID: 24246398
[TBL] [Abstract][Full Text] [Related]
15. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
16. Placental CD4
Harmon AC; Ibrahim T; Cornelius DC; Amaral LM; Cunningham MW; Wallace K; LaMarca B
Pregnancy Hypertens; 2019 Jan; 15():7-11. PubMed ID: 30825930
[TBL] [Abstract][Full Text] [Related]
17. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
[TBL] [Abstract][Full Text] [Related]
18. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]